Big Changes Coming in Treatment of Triple-Negative Breast Cancer
November 26th 2015The treatment paradigm for patients with triple-negative breast cancer is set to undergo a dramatic transformation, as standard chemotherapeutic approaches are perfected and novel antibody-drug conjugates are developed.
Kyprolis Continues to Advance in Multiple Myeloma
October 14th 2015The agent gained a priority review designation for use in combination with dexamethasone for patients with relapsed multiple myeloma following prior treatment with at least one therapy, based on findings from the phase 3 ENDEAVOR trial.